CPMV
Mosaic ImmunoEngineering Inc.Company Information
- Company Name
- Mosaic ImmunoEngineering Inc.
- CIK
- CIK0000836564
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CPMV: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- CPMV
SEC filing data through
Insider Sentiment
- Last purchase
- 2009-04-15
- Last sale
- 2009-10-27
- Shares purchased (TTM)
- 1,250,000
- Shares sold (TTM)
- 25,000
Institutional Sentiment
- As of
- 2025-09-30
- Institutional shares owned
- 1
- Shares outstanding
- 7,236,447
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 0.00%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Derivative Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Employee Related Liabilities Current | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | ||||||
| Accrued Professional Fees Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | 1 | - | ||||||
| Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Loans Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
| Liabilities Current | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | ||||||
| Convertible Debt | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 6 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Retained Earnings Accumulated Deficit | -10 | -10 | -10 | -9 | -9 | -9 | -9 | -9 | -8 | -8 | -8 | -8 | ||||||
| Stockholders Equity | -8 | -8 | -7 | -7 | -7 | -7 | -7 | -7 | -6 | -6 | -6 | -6 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Shares Outstanding | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialMosaic ImmunoEngineering Inc. (CPMV) — SEC Financial Statements & Analysis
Mosaic ImmunoEngineering Inc. (CPMV) is a biological products, (no diagnostic substances) company, incorporated in DE. Mosaic ImmunoEngineering Inc. trades on OTC as: CPMV. Mosaic ImmunoEngineering Inc. (CPMV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Mosaic ImmunoEngineering Inc. carries a market cap of $4.88M, a P/E ratio of -7.03x, a P/B ratio of -0.62x, an enterprise value of $6.58M, and an EV/EBITDA multiple of -10.54x. On profitability, it posts a Return on Equity (ROE) of 9.26% and a Return on Assets (ROA) of -2274.02%. Per share, it reports EPS of $-0.10, diluted EPS of $-0.10, free cash flow per share of $-0.01, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -13.37% year-over-year and EPS growth of -13.37% year-over-year. On the balance sheet, it maintains a current ratio of 0.00x, a quick ratio of 0.00x, working capital of $-6.33M, a debt-to-equity ratio of -1.00x, a debt ratio of 2.39K, an interest coverage ratio of -62.40x, free cash flow of $-57.11K (TTM), and net debt of $1.70M. Figures sourced from SEC EDGAR.
- Market Cap
- $4.88M
- P/E TTM
- -7.03x
- EPS TTM
- $-0.10
- P/B TTM
- -0.62x
- ROE TTM
- 9.26%
- ROA TTM
- -2274.02%
- Debt To Equity
- -1.00x
- Free Cash Flow TTM
- $-57.11K
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Mosaic ImmunoEngineering Inc. in?
Mosaic ImmunoEngineering Inc. (CPMV) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does CPMV trade on?
Mosaic ImmunoEngineering Inc. (CPMV) trades on the OTC.
Where is Mosaic ImmunoEngineering Inc. incorporated?
Mosaic ImmunoEngineering Inc. is incorporated in DE.
When was Mosaic ImmunoEngineering Inc. (CPMV)'s most recent SEC filing?
Mosaic ImmunoEngineering Inc. (CPMV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is CPMV's market cap?
Mosaic ImmunoEngineering Inc. (CPMV) has a market capitalization of $4.88M as of 2026-06-30.
What is CPMV's EPS (earnings per share)?
Mosaic ImmunoEngineering Inc. (CPMV)'s trailing twelve month EPS is $-0.10 as of 2026-06-30.
What is CPMV's ROE (return on equity)?
Mosaic ImmunoEngineering Inc. (CPMV)'s trailing twelve month Return on Equity (ROE) is 9.26% as of 2026-06-30.
What is CPMV's ROA (return on assets)?
Mosaic ImmunoEngineering Inc. (CPMV)'s trailing twelve month Return on Assets (ROA) is -2274.02% as of 2026-06-30.
What is CPMV's EV/EBITDA?
Mosaic ImmunoEngineering Inc. (CPMV)'s trailing twelve month EV/EBITDA is -10.54x as of 2026-06-30.